Table 3 Contribution of causes of death to changes in life expectancy and gender gap in life expectancy in Sweden between 1997 and 2018

Amenable neoplasms (C54-C55, C62, C67, C73, C81, C91, D10-D36)

0.02 (0.7)

.05 (1.3)

0.06 (1.1)

0.02 (0.6)

−0.04 (− 2.0)

Hypertensive diseases (I10-I15)

− 0.01 (− 0.3)

−0.01 (− 0.1)

0.02 (0.4)

0.02 (0.7)

0.00 (0.1)

Cerebrovascular diseases (I60-I69)

0.19 (8.3)

0.25 (6.2)

0.17 (3.3)

.08 (2.4)

−0.09 (− 5.1)

Pneumonia (J12-J18)

0.03 (1.4)

0.03 (0.6)

0.03 (0.5)

0.03 (1.0)

0.00 (0.3)

Total amenable

0.30 (13.2)

0.46 (11.1)

0.41 (7.8)

0.23 (6.7)

−0.18 (−9.8)

Preventable neoplasms (C00-C14, C15, C16, C22, C33-C34, C45)

0.06 (2.4)

0.28 (6.9)

0.36 (6.9)

0.14 (4.0)

−0.22 (− 12.0)

Alcohol related and illicit drug use diseases (F10, K70, K73, K74, F11-F16, F18-F19)

0.02 (0.8)

0.18 (4.4)

0.27 (5.2)

0.11 (3.4)

−0.16 (− 8.4)

Transport accidents (V01-V99)

0.06 (2.6)

0.15 (3.7)

0.19 (3.7)

0.10 (2.9)

−0.09 (− 5.1)

Accidental injury (W00-X59)

−0.06 (−2.7)

− 0.11 (− 2.7)

0.25 (4.7)

0.35 (10.5)

0.11 (5.9)

Suicide and self-inflicted injuries (X60-X84, Y10-Y34)

−0.01 (− 0.7)

0.08 (2.1)

0.38 (7.3)

0.30 (8.9)

−0.08 (−4.2)

Total preventable

0.12 (5.4)

0.68 (16.5)

1.56 (30.0)

1.10 (32.6)

−0.47 (−25.2)

Amenable & preventable neoplasms (C18-C21, C43, C50, C53)

0.23 (10.1)

0.06 (1.4)

−0.35 (−6.7)

− 0.23 (− 6.7)

0.12 (6.6)

Chronic obstructive pulmonary disorder (J40-J44)

− 0.01 (− 0.5)

0.04 (1.0)

0.02 (0.5)

− 0.03 (−1.0)

−0.06 (−3.1)

Total amenable & preventable

0.22 (9.9)

0.16 (4.0)

−0.22 (−4.1)

− 0.20 (−5.9)

0.02 (0.9)

Ischaemic heart disease (I20-I25)

0.39 (17.2)

1.14 (27.7)

1.25 (23.9)

0.44 (13.1)

−0.81(−43.6)

Total avoidable

1.03 (45.6)

2.44 (59.3)

3.00 (57.6)

1.57 (46.5)

−1.44 (− 77.7)

Non-avoidable

1.23 (54.4)

1.67 (40.7)

2.21 (42.4)

1.80 (53.5)

−0.41 (−22.3)

Total

2.26 (100)

4.11 (100)

5.22 (100)

3.37 (100)

−1.85 (100)